Example: Heart Attack

Clinical Trials on Hyperlipoproteinemia Type V

Total 9 results





    • NCT02069106
      Withdrawn
      Efficacy Study of Daily Pro-Omega LDL for Low-Density Lipoprotein Cholesterol and Triglyceride Reduction
      Conditions: Mixed Hyperlipoproteinemia
    • NCT01974297
      Unknown status
      Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid
      Conditions: Mixed Hyperlipidemia
    • NCT00941603
      Completed
      Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Participants With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675)
      Conditions: Primary Hypercholesterolemia; Mixed Hyperlipidemia
    • NCT00473655
      Completed
      Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients
      Conditions: Hypertriglyceridemia; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Hyperlipoproteinemia Type IIb; Hyperlipidemia
    • NCT00325455
      Terminated
      MK0859 Dose-Ranging Study (0859-003)
      Conditions: Hypercholesterolemia; Mixed Hyperlipemia
    • NCT00289900
      Completed
      Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024)
      Conditions: Mixed Hyperlipidemia
    • NCT00269204
      Completed
      Lipid Efficacy/Tolerability Study (0524A-020)
      Conditions: Primary Hypercholesterolaemia; Mixed Hyperlipidaemia
    • NCT00269217
      Completed
      Lipid Efficacy Study (0524B-022)(COMPLETED)
      Conditions: Primary Hypercholesterolemia; Mixed Hyperlipidemia
    • NCT00134238
      Terminated
      Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin.
      Conditions: Mixed Hyperlipidemia
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations